Destination 3, Call 3.1 - Tackling diseases (single stage - 2023)
Topics: Novel approaches for palliative and end-of-life care for non-cancer patients | Interventions in city environments | Anti-viral therapeutics for infectious diseases | ...
Topics: Novel approaches for palliative and end-of-life care for non-cancer patients | Interventions in city environments | Anti-viral therapeutics for infectious diseases | ...
Deadline: 13.04.2023
Eine Präsentation der Topics durch die Europäische Kommission finden Sie hier. Eine Frage-und-Antwort-Session zu den jeweiligen Topics finden Sie hier.
HORIZON-HLTH-2023-DISEASE-03-01-single-stage:
Novel approaches for palliative and end-of-life care for non-cancer patients (RIA)
♦ Cross-cutting priorities: SSH, Social Innovation
HORIZON-HLTH-2023-DISEASE-03-03-single-stage:
Interventions in city environments to reduce risk of non-communicable disease (Global Alliance for Chronic Diseases - GACD) (RIA)
♦ Cross-cutting priorities: SSH, International Cooperation
HORIZON-HLTH-2023-DISEASE-03-04-single-stage:
Pandemic preparedness and response: Broad spectrum anti-viral therapeutics for infectious diseases with epidemic potential (RIA)
♦ Cross-cutting priorities: EOSC and FAIR data
HORIZON-HLTH-2023-DISEASE-03-05-single-stage:
Pandemic preparedness and response: Sustaining established coordination mechanisms for European adaptive platform trials and/or for cohort networks (CSA)
HORIZON-HLTH-2023-DISEASE-03-06-single-stage:
Towards structuring brain health research in Europe (CSA)
♦ Cross-cutting priorities: SSH, Social Innovation
HORIZON-HLTH-2023-DISEASE-03-07-single-stage:
Relationship between infections and non-communicable diseases (RIA)
♦ Cross-cutting priorities: EOSC and FAIR data, Artificial Intelligence
HORIZON-HLTH-2023-DISEASE-03-17-single-stage:
Pandemic preparedness and response: Understanding vaccine induced-immunity (RIA)
♦ Cross-cutting priorities: SSH
HORIZON-HLTH-2023-DISEASE-03-18-single-stage:
Pandemic preparedness and response: Immunogenicity of viral proteins of viruses with epidemic and pandemic potential (RIA)